Skip to content

Author

César de la Fuente-Núñez

We have 9 of 210 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Establishing standardized evaluation protocols for peptide-target interaction prediction: the PTI-TAPE consensus framework eDelphi

Computational peptide-target interaction (PTI) prediction has advanced rapidly as a tool for drug discovery, yet the field lacks agreed evaluation standards. Discrepancies in metrics, negative sampling strategies, and dataset construction across publications currently render cross-study comparisons methodologically int...

William J. Waldock, Guang-Shun Wang, A. Darzi et al. · 0 citations
Open access Aug 2026

Ancient human mitochondrial genomes encode antimicrobial peptides

Mitochondria are bacteria-derived organelles that coordinate major innate immune pathways, but whether mitochondrial genomes themselves encode direct antimicrobial functions is underexplored. Here, we test the hypothesis that ancient human mitochondrial DNA is not only an evolutionary record, but also contains encrypte...

M. D. Torres, A. Ali, Hyun-Su Lee et al. · 0 citations
Open access Sep 2026

Designing antimicrobials with programmable mechanism and safety

OmegAMP, a conditional diffusion framework controlling net charge, mean hydrophobicity, and sequence length, supporting de novo, analog, and motif-guided design, opens a programmable route to new peptide antibiotics whose mechanism and safety follow from the chosen prototype.

Paulina Szymczak, Marcelo Der Torossian Torres, Diogo Soares et al. · 0 citations
Review Aug 2026

Machine learning for biomaterials design

This Review surveys machine learning methods, including surrogate modelling, generative design and active learning loops, for predicting and optimizing properties across metals, polymers, hydrogels, ceramics and biological biomaterials, and outlines key datasets, challenges, and future autonomous discovery pipelines.

Xiao-Qiong Xia, Tianang Leng, Andrés J. García et al. · 3 citations
Book Open access Aug 2026

The Forgetting-Learning Trade-off: Making Reinforcement Learning Work for Protein Language Models

Diagnostics reveal that RL on PLMs is governed by two reward properties: verifiability, whether the reward is a fixed environment or a learned surrogate vulnerable to distribution shift, and coverage, the fraction of sequence space giving an informative gradient.

Hanqun Cao, Hongrui Zhang, Junde Xu et al. · 0 citations
Book Open access Aug 2026

The Forgetting-Learning Trade-off: Making Reinforcement Learning Work for Protein Language Models

Reinforcement learning (RL) is increasingly applied to Protein Language Models (PLMs), yet its effectiveness varies across tasks, and standard metrics such as pass@k can rise even when the model's solvable problem set is shrinking. We introduce two capability-level diagnostics. The Expansion-Shrinkage Ratio (ESR) measu...

Hanqun Cao, Hongrui Zhang, Junde Xu et al. · 0 citations
Open access Aug 2026

Peptide structural plasticity is predictable from sequence and environment

ApexFold, an environment-conditioned AI framework that combines sequence representations with physicochemical descriptors of the surrounding medium to predict circular-dichroism-derived fractions of α-helical, β-like, and unstructured conformations is developed.

M. D. Torres, Hanqun Cao, César de la Fuente-Núñez · 0 citations
Open access Jul 2026

Design of a cyclic peptide targeting intracellular Staphylococcus aureus

Findings identify cyclotide grafting as a strategy to improve peptide stability and intracellular delivery, and support MCo-KTR2 as a scaffold for further optimization against intracellular MRSA infections.

Álvaro Mourenza, Jesús Llano-Verdeja, Pablo Castañera et al. · 0 citations
Review Jul 2026

Mining the code of life for new antibiotics.

The transition from classical "dirt mining" and phenotypic screening toward digital discovery approaches that treat chemical structures and biological sequences as searchable, engineerable substrates for antibiotic innovation is reviewed.

A. Crysler, César de la Fuente-Núñez · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.